Roger Jeffs
North America, North Carolina, United States, Chapel Hill
Description
Roger Jeffs retired as President and co-CEO at United Therapeutics in 2016 after a successful 18-year tenure. Dr. Jeffs joined United Therap...
Investor Profile
Roger Jeffs has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Post Ipo Equity rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biopharma, Biotechnology, Health Care.
Stage Focus
- Post Ipo Equity (100%)
Country Focus
- United States (100%)
Industry Focus
- Biopharma
- Biotechnology
- Health Care
- Nanotechnology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
